Vitoria-Gasteiz School of Nursing, University of the Basque Country (UPV/EHU), Jose Atxotegi, 01009 Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Jose Atxotegi, 01009 Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Jose Atxotegi, 01009 Vitoria-Gasteiz, Spain.
Bioaraba Health Research Institute, Jose Atxotegi, 01009 Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Jose Atxotegi, 01009 Vitoria-Gasteiz, Spain.
Aust Crit Care. 2024 Mar;37(2):230-235. doi: 10.1016/j.aucc.2023.06.009. Epub 2023 Aug 10.
More than 70% of patients demonstrate pain after endotracheal aspiration. Tools are needed to objectify the need for analgesia in non-communicative critically ill patients.
The objective of this study was to identify the lowest intensity electrical stimulus for detecting pain before daily care interventions.
Study of diagnostic tests to assess pupillometry to detect pain through the pupillary dilation response to noxious stimuli versus the Behavioural Pain Scale. Patients older than 18 years, under analgosedation, subjected to invasive ventilation, baseline Behavioural Pain Scale of 3, and Richmond Agitation-Sedation Scale between -1 and -4 were studied. We assessed the Behavioural Pain Scale and the pupillary dilation response to 10, 20, 30, and 40 mA stimuli. We studied the diagnostic performance based on sensitivity and specificity, negative predictive value, positive predictive value, and accuracy of the selected points after the different stimulations. AlgiScan® Pupillometer measured the pupillary dilation response. The presence of pain was considered as a Behavioural Pain Scale score of ≥4. Significance was defined as p <0.05.
Measurements were performed on 31 patients. In the 20 mA stimulus, we found an area under the curve of 0.85 (0.69-1.0). The cut-off point of pupillary dilation was 11.5%, with a sensitivity of 100% (34.2-100) and a specificity of 75.9% (57.9-87.8). This point had an accuracy of 77.4 (60.2-88.6) and a Youden's Index of 0.8.
Pupillary variation measurement during a 20 mA stimulus could help assess the need for analgesia before potentially painful interventions. Further studies are needed to confirm this.
Phase 1 of the project PUPIPAIN ClinicalTrials.gov Identifier: NCT04078113.
超过 70%的患者在气管内吸引后会出现疼痛。需要有工具来客观评估非语言交流的危重症患者的镇痛需求。
本研究的目的是确定在日常护理干预前检测疼痛的最低强度电刺激。
本研究为诊断性测试,通过瞳孔对有害刺激的扩张反应来评估瞳孔测量法,以检测疼痛,与行为疼痛量表(BPS)进行对比。研究对象为年龄大于 18 岁、接受镇静镇痛、接受有创通气、基线 BPS 评分为 3、Richmond 躁动-镇静量表评分为-1 至-4 的患者。我们评估了行为疼痛量表和 10、20、30 和 40 mA 刺激的瞳孔扩张反应。我们研究了不同刺激后选择的点的诊断性能,包括敏感性和特异性、阴性预测值、阳性预测值和准确性。AlgiScan®瞳孔计测量瞳孔扩张反应。疼痛的存在被定义为 BPS 评分≥4。有统计学意义的定义为 p<0.05。
对 31 名患者进行了测量。在 20 mA 刺激下,我们发现曲线下面积为 0.85(0.69-1.0)。瞳孔扩张的截断点为 11.5%,敏感性为 100%(34.2-100),特异性为 75.9%(57.9-87.8)。该点的准确性为 77.4%(60.2-88.6),Youden 指数为 0.8。
在 20 mA 刺激期间测量瞳孔变化可以帮助评估潜在疼痛干预前的镇痛需求。需要进一步的研究来证实这一点。
项目第一阶段 PUPIPAIN ClinicalTrials.gov 标识符:NCT04078113。